Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Oldroyd

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
JACC. Cardiovascular Interventions|August 26, 2017
Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation SubstudyDidier Carrié, Ian Menown, Keith Oldroyd, et al.
JACC. Cardiovascular Interventions|July 24, 2010
The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarctionRoss McGeoch, Stuart Watkins, Colin Berry, et al.
JACC. Cardiovascular Interventions|December 22, 2018
Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society DatabaseTim Kinnaird, Richard Anderson, Sean Gallagher, et al.
American Heart Journal|April 30, 2017
Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trialMiguel E Lemmert, Keith Oldroyd, Paul Barragan, et al.
JACC. Cardiovascular Interventions|February 8, 2020
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society DatabaseTim Kinnaird, Thomas Johnson, Richard Anderson, et al.
Circulation. Cardiovascular Interventions|June 13, 2013
Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarctionJamie Layland, David Carrick, Margaret McEntegart, et al.
The American Journal of Cardiology|December 8, 2016
Comparison of Characteristics and Complications in Men Versus Women Undergoing Chronic Total Occlusion Percutaneous InterventionVinoda Sharma, William Wilson, William Smith, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 17, 2015
Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registryPhilip Urban, Mariano Valdés, Ian Menown, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Christophe Dubois, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
JACC. Cardiovascular Interventions|August 26, 2017
Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation SubstudyDidier Carrié, Ian Menown, Keith Oldroyd, et al.
JACC. Cardiovascular Interventions|July 24, 2010
The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarctionRoss McGeoch, Stuart Watkins, Colin Berry, et al.
JACC. Cardiovascular Interventions|December 22, 2018
Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society DatabaseTim Kinnaird, Richard Anderson, Sean Gallagher, et al.
American Heart Journal|April 30, 2017
Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trialMiguel E Lemmert, Keith Oldroyd, Paul Barragan, et al.
JACC. Cardiovascular Interventions|February 8, 2020
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society DatabaseTim Kinnaird, Thomas Johnson, Richard Anderson, et al.
Circulation. Cardiovascular Interventions|June 13, 2013
Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarctionJamie Layland, David Carrick, Margaret McEntegart, et al.
The American Journal of Cardiology|December 8, 2016
Comparison of Characteristics and Complications in Men Versus Women Undergoing Chronic Total Occlusion Percutaneous InterventionVinoda Sharma, William Wilson, William Smith, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 17, 2015
Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registryPhilip Urban, Mariano Valdés, Ian Menown, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Christophe Dubois, et al.
Pageof 7